Abstract
We report a new approach to monitor drug release from nanocarriers via a paclitaxel–methylene blue conjugate (PTX-MB) with redox activity. This construct is in a photoacoustically silent reduced state inside poly(lactic-co-glycolic acid) (PLGA) nanoparticles (PTX-MB@PLGA NPs). During release, PTX-MB is spontaneously oxidized to produce a concentration-dependent photoacoustic signal. An in vitro drug-release study showed an initial burst release (25 %) between 0–24 h and a sustained release between 24–120 h with a cumulative release of 40.6 % and a 670-fold increase in photoacoustic signal. An in vivo murine drug release showed a photoacoustic signal enhancement of up to 649 % after 10 hours. PTX-MB@PLGA NPs showed an IC50 of 78 μg mL−1 and 44.7±4.8 % decrease of tumor burden in an orthotopic model of colon cancer via luciferase-positive CT26 cells.
Original language | English (US) |
---|---|
Pages (from-to) | 4678-4683 |
Number of pages | 6 |
Journal | Angewandte Chemie - International Edition |
Volume | 59 |
Issue number | 12 |
DOIs | |
State | Published - Mar 16 2020 |
Externally published | Yes |
Keywords
- antitumor agents
- cancer therapy
- drug delivery
- paclitaxel
- photoacoustic imaging
ASJC Scopus subject areas
- Catalysis
- General Chemistry